Tempus AI Cash on Hand 2023-2024 | TEM

Tempus AI cash on hand from 2023 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Tempus AI cash on hand for the quarter ending December 31, 2024 was $0.448B, a 126.88% increase year-over-year.
  • Tempus AI cash on hand for 2024 was $0.448B, a 126.88% increase from 2023.
  • Tempus AI cash on hand for 2023 was $0.198B, a 34.78% decline from 2022.
  • Tempus AI cash on hand for 2022 was $0.303B, a 0% decline from .
Tempus AI Annual Cash on Hand
(Millions of US $)
2024 $448
2023 $198
2022 $303
Tempus AI Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $448
2024-09-30 $466
2024-06-30 $490
2024-03-31 $95
2023-12-31 $198
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $303
Sector Industry Market Cap Revenue
Medical Medical Information Systems $9.826B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.476B 53.14
Hims & Hers Health (HIMS) United States $9.069B 145.79
Inspire Medical Systems (INSP) United States $4.756B 92.38
IRhythm Technologies (IRTC) United States $4.186B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $2.016B 12.47
Schrodinger (SDGR) United States $1.847B 0.00
Clover Health Investments (CLOV) United States $1.706B 0.00
Phreesia (PHR) United States $1.512B 0.00
Omnicell (OMCL) United States $1.460B 31.48
Azenta (AZTA) United States $1.232B 57.36
10x Genomics (TXG) United States $1.031B 0.00
Fulgent Genetics (FLGT) United States $0.634B 0.00
Butterfly Network (BFLY) United States $0.566B 0.00
Talkspace (TALK) United States $0.537B 319.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.456B 0.00
TruBridge (TBRG) United States $0.392B 0.00
Claritev (CTEV) United States $0.362B 0.00
Health Catalyst (HCAT) United States $0.294B 0.00
Nyxoah SA (NYXH) Belgium $0.208B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.202B 0.00
Pulmonx (LUNG) United States $0.152B 0.00
American Well (AMWL) United States $0.116B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.43
111 (YI) China $0.072B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Precipio (PRPO) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00